Principal
IQVIA, United States
Dr. Reid D’Amico is a Principal of Regulatory Science at IQVIA. In his time with the company, he has successfully led multi-stakeholder engagements to understand the impact of policies and regulations on broader ecosystems. In addition, Reid has overseen complex program engagements with large companies in various domains such as digital health, oncology/rare disease development, labeling expansion, and health equity. Reid is experienced in spearheading thought leadership and enacting scientific and policy change by speaking at major conferences, leading engagements with Duke Margolis, and supporting trade organizations in real-world evidence and digital health data policy.
Prior to his role at IQVIA, Dr. D’Amico worked at Deloitte as a Life Sciences and Regulatory Specialist Master. In this position, he managed teams of scientists and regulatory affairs professionals to navigate complex scientific and policy issues in the medical devices, biologics, and drugs space. He fostered key relationships with critical stakeholders, including professional organizations and FDA's senior leadership. He also led strategic scientific meetings with federal health officials to discuss clinical evidence and led partnership efforts with SME Oncologists to integrate health data into clinical and scientific frameworks.
Dr. D’Amico also served as a expert policy and technical adviser to senior members at FDA's Center for Devices and Radiological Health. He managed the development of draft legislation and guidance documents, monitored a portfolio of medical devices, and led complex multi-stakeholder public health programs. He also played a key role in finalizing the draft premarket guidances for medical device cybersecurity and served as the medical device patient engagement scientific lead.
Disclosure information not submitted.
Monday, August 26, 2024
3:30 PM – 5:00 PM CEST
Wednesday, August 28, 2024
9:00 AM – 9:05 AM CEST